RGNX
Regenxbio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RGNX fundamentals
Regenxbio (RGNX) released its earnings on Nov 6, 2025: revenue was 29.70M (YoY +22.78%), beat estimates; EPS was -1.2 (YoY -2.56%), beat estimates.
Revenue / YoY
29.70M
+22.78%
EPS / YoY
-1.2
-2.56%
Report date
Nov 6, 2025
RGNX Earnings Call Summary for Q3,2025
- RGX-202 Milestone: Pivotal trial enrollment complete; BLA submission in mid-2026 with potential accelerated approval. Confirmatory trial enrolling 30 patients to support full approval.
- MPS II Progress: FDA inspections cleared; BLA on track for February 2026 PDUFA date. Commercial doses via Nippon Shinyaku expected early 2026.
- Financial Strength: $302 million cash balance with runway into 2027, supported by $145 million healthcare royalty monetization and $110 million Nippon Shinyaku payment.
- Retinal Leadership: Wet AMD trial largest in gene therapy history; DR program to initiate Phase IIb/III in 2026 with AbbVie collaboration.
EPS
Revenue
Revenue & Expenses
RGNX has released its 2025 Q3 earnings report, with revenue of 29.73M, reflecting a YoY change of 22.88%, and net profit of -61.94M, showing a YoY change of -3.93%. The Sankey diagram below clearly presents RGNX's revenue sources and cost distribution.
Key Indicators
Regenxbio (RGNX) key financial stats and ratios, covering profitability, financial health, and leverage.
Regenxbio (RGNX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Regenxbio (RGNX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Regenxbio (RGNX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Regenxbio (RGNX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Regenxbio (RGNX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Regenxbio year over year?Did Regenxbio beat or miss consensus estimates last quarter?What guidance did Regenxbio's management provide for the next earnings period?What were the key takeaways from Regenxbio's earnings call?What is Regenxbio's gross profit margin?What were the key takeaways from Regenxbio’s earnings call?What is Regenxbio's latest dividend and current dividend yield?What does Regenxbio do and what are its main business segments?
